Health Issues
Issue Code: HCR
🤖
AI Overview
Health Issues is one of the 79 issue categories tracked under the Lobbying Disclosure Act. With $2.7B in total lobbying spend across 100.9K filings, it ranks among the most heavily lobbied policy areas in Washington. The money flowing into this issue reflects how much is at stake for the industries involved.
$2.7B
Total Lobbying Spend
100.9K
Filings
50
Top Clients
Spending by Year
| Year | Spending | Filings |
|---|---|---|
| 2018 | $248.6M | 10.3K |
| 2019 | $265.5M | 10.6K |
| 2020 | $327.3M | 13.2K |
| 2021 | $343.0M | 12.9K |
| 2022 | $387.3M | 14.0K |
| 2023 | $389.8M | 14.2K |
| 2024 | $331.3M | 12.1K |
| 2025 | $397.7M | 13.5K |
Biggest Spenders
| # | Client | Spending |
|---|---|---|
| 1 | HR Policy Association | $20.0M |
| 2 | Pharmaceutical Research and Manufacturers of America | $17.7M |
| 3 | Gilead Sciences, INC. | $13.1M |
| 4 | Pharmaceutical Research and Manufacturers of America (PHRMA) | $12.5M |
| 5 | PHRMA | $12.4M |
| 6 | Blue Cross Blue Shield Association | $10.0M |
| 7 | Johnson & Johnson Services, INC. | $9.1M |
| 8 | Cigna Corporation | $8.6M |
| 9 | Biotechnology Innovation Organization | $8.2M |
| 10 | Illumina, INC. | $7.9M |
| 11 | Genentech, INC. | $7.8M |
| 12 | Pharmaceutical Research & Manufacturers of America INC | $7.7M |
| 13 | Centene Corporation | $7.6M |
| 14 | Abbott Laboratories | $7.6M |
| 15 | Altria Client Services LLC | $7.4M |
| 16 | Unitedhealth Group, INC. | $7.2M |
| 17 | Alkermes, INC. | $6.9M |
| 18 | Air Evac Lifeteam | $6.8M |
| 19 | Novartis | $6.7M |
| 20 | Pfizer INC. | $6.7M |
| 21 | Cvs Health | $6.6M |
| 22 | American Hospital Association | $6.6M |
| 23 | Novo Nordisk INC. | $6.5M |
| 24 | Bayer Corporation | $6.4M |
| 25 | Eli Lilly and Company | $6.4M |
Top Firms
Tarplin, Downs & Young, LLC$102.7M
BGR Government Affairs$80.5M
Mehlman Consulting, INC.$56.5M
Forbes-tate$55.9M
Alston & Bird LLP$52.4M
Capitol Counsel LLC$49.8M
Tiber Creek Group$48.5M
Thorn Run Partners$44.3M
Invariant LLC$37.2M
Van Scoyoc Associates$36.6M
Avenue Solutions$33.9M
What They Lobby For
- monitor for tax issues affecting real estate investment trusts general health care policy affecting hospitals and physician practices
- allowing growth for hospitals with physician ownership
- drug pricing, drug supply chain, opioid abuse epidemic, Medicare Part D
- Controlled Substance act improvements. Opioid overdose death reduction. Alprazolam rescheduling.
- Funding opportunities for first responder products
- Matters related to healthcare, hospital ratings, and funding opportunities.
- Help in the reduction of opioid use and related addiction.
- Implementation of Public Law 115-80
- Development of government-private partnerships to advance Alzheimer's therapies.
- Issues surrounding Medicare Dependent Hospitals Preserving Medicare reimbursement rates for rural public hospitals serving a disproportionate Medicare/Medcaid patient mix.
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.